Bicycle Therapeutics plc
BCYC
$7.12
$0.020.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.95% | -17.16% | -2.07% | -27.60% | -49.88% |
| Total Depreciation and Amortization | 3.79% | -4.11% | -21.55% | 32.44% | -1.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.83% | 71.86% | -38.77% | -14.94% | 7.45% |
| Change in Net Operating Assets | 86.96% | -198.91% | 3,801.30% | 105.86% | 71.21% |
| Cash from Operations | 15.73% | -819.22% | 76.41% | 10.74% | 37.03% |
| Capital Expenditure | 17.55% | -64.13% | 15.40% | -3.57% | -3,400.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.55% | -64.13% | 15.40% | -3.57% | -3,400.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.98% | -2.38% | 99.87% | -- | -- |
| Issuance of Common Stock | -50.00% | -99.18% | -- | -- | 29,274.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.76% | -120.20% | 100.64% | -105.81% | 29,274.99% |
| Foreign Exchange rate Adjustments | 286.11% | 126.28% | -205.07% | 982.81% | 53.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.36% | -663.07% | 83.91% | -113.98% | 826.48% |